Advances in Diabetes Care

Advances in Diabetes Care

Monday, June 3, 2019 (6:30 AM - 9:00 AM) (EDT)


Advances in Diabetes Care

June 3 - Monday

Diabetes Clinical UpdateNew insights on both Type 1 Diabetes and Type 2 Diabetes from the perspective of a leading clinical researcher. Dr. Gabbay, the Chief Medical Officer of the Joslin Diabetes Center, will moderate our program, and he will provide an overview of the best clinical practices in diabetes care today, as well as the challenges involved in helping people with diabetes to effectively manage their diabetes.

Smart Devices and WearablesHow connected health is impacting care, medication and insulin titration and adherence, and clinical and economic outcomes for payers, providers, employers, etc. James White, the co-founder of Common Sensing, a smart insulin pen company, will describe the advances underway in using real time glucose information to help patients and their care teams to optimize diabetes management to drive better clinical and economic outcomes.

Artificial Pancreas and AIClosed loop systems, AI and cloud base diabetes decision support tools, and telemedicine/remote monitoring solutions. Dr. Trang Ly, the Chief Medical Officer at Insulet, will discuss how continuous glucose monitor (CGM) systems, with smart AI and closed loop algorithms, will provide patients with a worry free "artificial pancreas" that will mimic a normal pancreas, helping keep people with diabetes in control of their blood glucose levels.

Advancements in EncapsulationCreating an environment for new beta cells to thrive, responding to glucose and producing insulin, and being protected from the immune system. Lastly, Dr. Linda Tempelman, CEO, Giner Life Sciences, will discuss how encapsulization devices can provide a nourishing and protected environment utilizing an oxygen delivery technology for use with a fully-implanted Type I Diabetes (T1D) cell therapy treatment employing immune-isolation capsule technology for allogenic pancreatic islets or stem-cell derived pancreatic islet-like cell clusters.

June 3 - Monday
Regis College
Weston, MA 

Key insights on tackling
the diabetes pandemic and the
great work underway to drive
true advances in diabetes care

Earlybird Fees by May 27 Member/Alliance Partner - $30   Non-member - $45   Student (member) - $10   Student (non-member) - $15Gold Member - No Charge     Event Sponsors

Who Should Attend: 
  • Healthcare Executives in Diabetes and Chronic Disease
  • Digital/Connected Health
  • Healthcare AI and Support Providers
  • Medical Device Entrepreneurs
  • Investors in the MedTech Space
Fine Arts Center Regis College
235 Wellesley Street
Weston, MA 02493-1545 United States
Event Contact

Powered By GrowthZone

Promote your event here!

Contact us for more information.